Publication | Closed Access

Additive prognostic value of interleukin-6 at peak phase of dobutamine stress echocardiography in patients with coronary artery disease. A 6-year follow-up study

InflammationPeak PhaseCardiovascular DiseaseMyocardial InfarctionClinical EpidemiologyInflammatory MarkerDobutamine Stress EchocardiographyAdditive Prognostic ValuePublic HealthMedicineCardiologyEmergency MedicineCoronary Artery DiseaseCardiovascular Imaging